SCHEMBL8898863

SCHEMBL8898863

N#Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1

nearest known ligand 0.74

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 8/20 0.74
ABCG2 Q9UNQ0 5/20 0.69
MERTK Q12866 1/20 0.68
KDM1A O60341 1/20 0.58
KDM4E B2RXH2 1/20 0.57
MEN1 O00255 1/20 0.57
ALDH1A1 P00352 1/20 0.57
LMNA P02545 1/20 0.57
TP53 P04637 1/20 0.57
CYP1A2 P05177 1/20 0.57
MAPT P10636 1/20 0.57
TSHR P16473 1/20 0.57
KMT2A Q03164 1/20 0.57
HSD17B10 Q99714 1/20 0.57
SLC2A1 P11166 1/20 0.56
EGFR P00533 1/20 0.53
KDR P35968 1/20 0.53
ABCB1 P08183 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8890523 0.99 NPY5R (0.72) NPY5RABCG2MERTKKDM1AKDM4E
SCHEMBL8901666 0.88 ABCG2 (0.71) NPY5RABCG2KDM4EMEN1ALDH1A1
Hydrochloric Acid SCHEMBL8890746 0.88 NPY5R (0.77) NPY5RABCG2MERTKMEN1ALDH1A1
Hydrochloric Acid SCHEMBL8901465 0.87 ABCG2 (0.70) NPY5RABCG2KDM4EMEN1ALDH1A1
SCHEMBL8890705 0.86 NPY5R (0.67) NPY5RABCG2MERTKKDM4EMEN1
SCHEMBL2591063 0.86 NPY5R (1.00) NPY5RABCG2MERTKMEN1TP53
Hydrochloric Acid SCHEMBL8889951 0.85 NPY5R (0.66) NPY5RABCG2MERTKKDM4EMEN1
Hydrochloric Acid SCHEMBL6039677 0.85 NPY5R (0.96) NPY5RABCG2KDM4EMEN1TP53
SCHEMBL2204708 0.84 MERTK (0.60) NPY5RABCG2MERTKKDM1ASLC2A1
SCHEMBL31471782 0.84 NPY5R (0.58) NPY5RABCG2MERTKKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020822-A1 QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST NOVARTIS AG (CH) 1997-06-12 WO claimed